Restatement communication upon adoption of IFRS 16, Leases with full retrospective application

IFRS 16, Leases is mandatory for annual reporting periods starting on or after 1 January 2019. Medicover has adopted the standard from 1 January 2019. The standard applies new ways of accounting for leases in a unified approach and replaces the previous standard IAS 17, Leases. The standard impacts Medicover as a lessee and requires recognition in the statement of financial position of right-of-use assets and lease liabilities. This release provides information on the impact of the implementation of the standard on the Group’s IFRS financial statements for 2018 as restated for the full retrospective application of the standard. As at 31 December 2018 the impact is principally an increase in fixed assets of €116.4m and an increase in financial liabilities of €124.9m and a decrease of shareholders’ equity of €6.4m.

For the complete IFRS 16 restatement and changes to accounting policies please see attachment to this release.

A conference call for media, financial analysts and investors will be held today at 14.30 CEST.

To join the conference call please dial-in using the following details at least 10 minutes before the start of the call:

Sweden: +46 (0) 850 692 185

UK: +44 (0) 203 009 5710

Germany: +49 (0) 692 222 4910

Code: 5152879

A live audio webcast of the conference call will be available at:

https://edge.media-server.com/m6/p/whbp6u3y

For further information, please contact:

Hanna Bjellquist, Head of Investor Relations

+46 703 033 272
hanna.bjellquist@medicover.com

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2018, Medicover had revenues around €672 millions and 20,970 employees. For more information, go to www.medicover.com